---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-24-000004"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:18:36.008046+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Systems Q4 preliminary revenue ~$192.4M (+40% YoY); FY2024 guidance $775-785M

## Summary
- Q4 2023 revenue expected $192.3-192.5M, ~40% increase over Q4 2022.
- FY2023 revenue expected $624.6-624.8M, ~53% increase over FY2022.
- Added 78 new U.S. centers in Q4, total 1,180; 13 new sales territories, total 287.
- Initial FY2024 revenue guidance $775-785M, 24-26% growth over FY2023.
- Company expects to report a profitable Q4 when full results are released Feb 6, 2024.

## SEC filing metadata
- accession: 0001609550-24-000004
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000004/0001609550-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000004/insp-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-24-000004
- JSON: https://secwatch.observer/filing/0001609550-24-000004.json
- Plain text: https://secwatch.observer/filing/0001609550-24-000004.txt

## Key facts
- Earnings Releases
  Inspire Medical Systems, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue Revenue for the fourth quarter of 2023 is anticipated to be in the range of $192.3 million to $192.5 million. Guidance initiated.
  - Period: the fourth quarter and full year ended December 31, 2023
  - Revenue: Revenue for the fourth quarter of 2023 is anticipated to be in the range of $192.3 million to $192.5 million
  - Guidance: initiated
  - Result: preliminary results
  source text: Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2023 and Provides Initial 2024 Guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000004/0001609550-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.